For people with rheumatoid arthritis, methotrexate is the treatment of choice in reducing pain and inflammation. But there’s evidence the Pain Relief Arthritis Drug can activate a virus that can increase the risk of Leukemia Cancer and similar cancers in some patients.The study appears in this month’s issue of the Journal of the National Cancer Institute. A number of reports have linked Pain Relief Arthritis Drug methotrexate with lymphoma and similar cancers of the lymph glands, says senior researcher Shannon C. Kenney, MD, a microbiologist and infectious disease specialist with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill.
Also, studies have shown that when rheumatoid arthritis patients quit taking methotrexate, their Leukemia Cancer went into regression, another sign that the Pain Relief Arthritis Drug directly contributes to the Leukemia Cancer , she tells WebMD. Some studies have indicated that the Pain Relief Arthritis drug’s immune-weakening effect places people at risk for viral-associated lymphomas.Another factor in this story: Epstein-Barr virus (EBV), a herpes virus that is common among adults. Some 90% of adults are said to have EBV, which is associated with mononucleosis and other infections — but in the vast majority of people, the virus remains latent, never causing an infection, says Kenney.